Neurology News

Ataluren preserved muscle burst activity across a range of ambulatory tests compared with placebo in boys with nonsense mutation Duchenne muscular dystrophy, according to a poster at the 2023 MDA Clinical & Scientific Conference.

Ataluren preserved upper limb function in boys with nonsense mutation Duchenne muscular dystrophy, according to a poster presented at the MDA Clinical & Scientific Conference.

Left undiagnosed and untreated, obstructive sleep apnea can result in several poor consequences related to health, work and relationships, according to a press release from the American Academy of Sleep Medicine, or AASM.

Smoking consistently after acute ischemic stroke was associated with increased risk for CV events and death compared with never smoking, researchers reported.

Treatment with casimersen increased exon 45 skipping from baseline and was well-tolerated in children with Duchenne muscular dystrophy, according to a poster at the 2023 MDA Clinical & Scientific Conference.

Rozanolixizumab improved myasthenia gravis symptoms in people with muscle-specific kinase antibody-positive disease, according to a poster presented at the 2023 MDA Clinical & Scientific Conference in Dallas.

As a part of a comprehensive health care compliance program, every medical practice should conduct regular exclusion screening.

The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted unanimously that tofersen, an antisense oligonucleotide for the treatment of superoxide dismutase 1 ALS, may be considered for potential accelerated approval.

In this edition, FDA clears lab blood test for evaluating concussion, marriage linked to lower risk for dementia, FDA approves nasal spray for migraine in adults and more.

Researchers reported no differences in functional status or survival in patients with ALS treated with ravulizumab compared with placebo, according to a poster presented at the 2023 MDA Clinical & Scientific Conference.